Two Cases of Refractory Adult-Onset Still's Disease Responding to Anakinra

Ji-Min OH; Hyungjin KIM; Jaejoon LEE; Joong-Kyong AHN; You-Sun LEE; Eun-Mi KOH; Hoon-Suk CHA; Ji-Min OH; Hyungjin KIM; Jaejoon LEE; Joong-Kyong AHN; You-Sun LEE; Eun-Mi KOH; Hoon-Suk CHA.
Korean Journal of Medicine ; : 520-524, 2012.
Artículo en Ko | WPRIM | ID: wpr-741078

Documentos relacionados

  1. The treatment of adult-onset Still's disease with anakinra, a recombinant human IL-1 receptor antagonist: a systematic review of literature.
  2. [Adult-onset Still's disease : Diagnosis and treatment according to the new S2e guidelines of the German Society of Rheumatology (DGRh)].
  3. Fever and flagellate dermatosis in an otherwise healthy woman.
  4. Anakinra for Adult-Onset Still's Disease Despite Old Age.
  5. Cardiac involvement in adult-onset Still's disease: Manifestations, treatments and outcomes in a retrospective study of 28 patients.
  6. JAK inhibitors in difficult-to-treat adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis.
  7. Systematic Review and Metaanalysis of Pharmacological Interventions in Adult-Onset Still Disease and the Role of Biologic Disease-Modifying Antirheumatic Drugs.
  8. Patients' experience and tolerability with canakinumab and anakinra for the treatment of adult-onset Still's disease.
  9. [Adult-onset Still's disease : Diagnosis and treatment according to the new S2e guidelines of the German Society of Rheumatology (DGRh)].
  10. The clinical heterogeneity of adult onset Still's disease may underlie different pathogenic mechanisms. Implications for a personalised therapeutic management of these patients.